R. Barrier

发表

Obesity and Type 2 Diabetes Mellitus: A Population-based Study of Adolescents

L. Edwards, T. Sipahi, S. Fırat, 2004, Journal of pediatric endocrinology & metabolism : JPEM.

A phase II study of carboplatin, etoposide and exisulind in patients with extensive stage small cell lung cancer: CALGB 30104

Michael R. Green, R. Govindan, J. Herndon, 2005 .

Enumerating Antigen-Specific T-Cell Responses in Peripheral Blood: A Comparison of Peptide MHC Tetramer, ELISpot, and Intracellular Cytokine Analysis

D. Niedzwiecki, H. Lyerly, M. Morse, 2005, Journal of immunotherapy.

Impact of race on survival in men with metastatic hormone-refractory prostate cancer.

S. George, E. Small, N. Vogelzang, 2004, Urology.

Dose-intense cyclophosphamide and etoposide for patients with refractory or high-risk non-Hodgkin's lymphoma.

C. Decastro, D. Rizzieri, Joseph O. Moore, 2004, Clinical lymphoma.

Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study.

E. Small, B. Rini, W. Stadler, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Dose Escalation and Phase II Study of Gemtuzumab Ozogamicin (GO) with High-Dose Cytarabine (HiDAC) for Patients (pts) with Refractory or Relapsed Acute Myeloid Leukemia (AML): CALGB 19902.

R. Larson, W. Stock, J. Kolitz, 2004 .

Long-term changes in pulmonary function tests after definitive radiotherapy for lung cancer.

R. Clough, L. Marks, Sumin Zhou, 2003, International journal of radiation oncology, biology, physics.

Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis.

J. Lieberman, D. Perkins, L. Edwards, 2005, The American journal of psychiatry.

A phase II study of gemcitabine and capecitabine in metastatic renal cancer

E. Small, B. Rini, M. Ernstoff, 2006, Cancer.

A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers.

Robert C Barrier, Edward C Halperin, E. Halperin, 2003, International journal of radiation oncology, biology, physics.

Adjusting for observable selection bias in block randomized trials

Anastasia Ivanova, Vance W Berger, Robert C Barrier, 2005, Statistics in medicine.

A phase II study of gemcitabine (G) and capecitabine (C) in patients with metastatic renal cell cancer (mRCC): A report of Cancer and Leukemia Group B #90008.

E. Small, M. Ernstoff, J. Picus, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.